Overview

The Liver Transplantation program at MGUMST is led by the esteemed HPB (Hepato-Pancreato-Biliary) and transplant surgeon, Dr. Naimish N Mehta, renowned for his exceptional expertise in liver transplantation and complex HPB surgeries, with a track record of over 1500 transplants.

1500

Dr. Mehta leads a dedicated team of young, highly skilled professionals who work collaboratively to provide top-notch care. Their approach combines innovative techniques with personalized treatment strategies, ensuring that each patient's journey through treatment is a transformative experience leading to restored health and vitality.

In this program, a blend of advanced medical practices and compassionate care defines every patient's experience. The focus on cutting-edge procedures alongside tailored care plans sets a high standard for liver transplantation and related services supported by a dynamic team. This exemplifies a commitment to excellence in enhancing patients' health and well-being, making it a trusted destination for those in need of specialized medical care.

Core Competencies

We have a robust program offering both living and deceased donor liver transplant.

We have expertise in adult as well as pediatric transplants and offer transplant for the following diseases

End-stage liver disease (cirrhosis)

This can result from chronic conditions such as hepatitis B, hepatitis C, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), autoimmune hepatitis, or primary biliary cholangitis (PBC).

Acute/ fulminant liver failure

Rapid loss of liver function due to viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis E), drug-induced liver injury, autoimmune hepatitis, or other causes.

Liver cancer
(hepatocellular carcinoma or cholangiocarcinoma)

Liver transplantation may be considered for select patients with early-stage liver cancer who meet specific criteria.

Metabolic liver diseases

Inherited metabolic disorders such as Wilson's disease, hemochromatosis, alpha-1 antitrypsin deficiency, glycogen storage diseases, and certain urea cycle disorders may necessitate liver transplantation.

Biliary atresia

A congenital condition where the bile ducts are absent or blocked, leading to bile accumulation, liver damage, and eventual cirrhosis. Liver transplantation is often performed in infants with biliary atresia who do not respond to other treatments.

Primary sclerosing cholangitis (PSC)

A chronic liver disease characterized by inflammation and scarring of the bile ducts, which can lead to cirrhosis and liver failure.

Chronic hepatic venous outflow obstruction

Conditions such as Budd-Chiari syndrome, characterized by blockage of the hepatic veins, leading to liver congestion, cirrhosis, and eventual liver failure.

Achievements of the department
Highest number of liver transplants performed in the state of Rajasthan and many firsts to its credit
1st

Cadaveric liver transplant

1st

Living donor liver transplant

1st

Centre to perform LDLT for Acute Liver Failure (ALF)

1st

Liver transplant for Hepatocellular Carcinoma (HCC)

1st

Paediatric liver transplant conducted

1st

Paediatric liver transplant for acute liver failure

1st

Combined liver and kidney transplant

1st

Dual lobe liver transplant

Aims & Objectives

The Liver Transplantation program at MGUMST aims to be a leading center for liver disease treatment within the region and hopes to gain recognition as a reputable institution nationally and internationally. It is committed to providing high-quality patient care, fostering medical education, and conducting valuable research. By delivering comprehensive diagnostic and treatment services that align with international standards, patients receive streamlined care without the need for multiple referrals. This approach ensures that individuals dealing with liver-related conditions can access thorough treatment and support all in one place.

Furthermore, the department's focus on education, training, and research underscores its objective to play a significant role in the field of liver transplantation. The department aims to contribute to the advancement of liver disease understanding and management on a global scale through educating future medical professionals and engaging in research activities.

Through these ongoing efforts, the department endeavors to enhance liver transplant care standards and offer meaningful contributions to the medical community at large.